Literature DB >> 24090416

Fibrotic remodeling of tissue-engineered skin with deep dermal fibroblasts is reduced by keratinocytes.

Mathew Varkey1, Jie Ding, Edward E Tredget.   

Abstract

Two-thirds of burn patients with deep dermal injuries are affected by hypertrophic scars, and currently, there are no clinically effective therapies. Tissue-engineered skin is a very promising model for the elucidation of the role of matrix microenvironment and biomechanical characteristics and could help in the identification of new therapeutic targets for hypertrophic scars. Conventionally, tissue-engineered skin is made of heterogeneous dermal fibroblasts and keratinocytes; however, recent work has shown that superficial and deep dermal fibroblasts are antifibrotic and profibrotic, respectively. Furthermore, keratinocytes are believed to regulate the development and remodeling of fibrosis in skin. This study aimed to assess the influence of keratinocytes and layered fibroblasts on the characteristics of tissue-engineered skin. Layered fibroblasts and keratinocytes isolated from superficial and deep dermis and epidermis, respectively, of the lower abdominal tissue were independently co-cultured on collagen-glycosaminoglycan scaffolds, and the resulting tissue-engineered skin was assessed for differences in tissue remodeling based on the underlying specific dermal fibroblast subpopulation. Collagen production by deep fibroblasts but not by superficial fibroblasts was significantly reduced upon co-culture with keratinocytes. Also, keratinocytes in the tissue-engineered skin resulted in significantly reduced expression of profibrotic connective tissue growth factor and fibronectin, and increased expression of the antifibrotic matrix metalloproteinase-1 by deep fibroblasts but not by superficial fibroblasts. Tissue-engineered skin made of deep fibroblasts and keratinocytes had lower levels of small proteoglycans, decorin, and fibromodulin, and higher levels of large proteoglycan, versican, compared to tissue-engineered skin made of superficial fibroblasts and keratinocytes. Tissue-engineered skin made of deep fibroblasts and keratinocytes had lower expression of transforming growth factor (TGF)-α, interleukin (IL)-1, and keratinocyte growth factor but higher expression of platelet-derived growth factor and IL-6, compared to tissue-engineered skin made of superficial fibroblasts and keratinocytes. Furthermore, co-culture with keratinocytes reduced TGF-β1 production of deep but not superficial fibroblasts. Additionally, keratinocytes reduced the differentiation of deep fibroblasts to myofibroblasts in tissue-engineered skin constructs, but not that of superficial fibroblasts. Taken together, keratinocytes reduce fibrotic remodeling of the scaffolds by deep dermal fibroblasts. Our results therefore demonstrate that tissue-engineered skin made specifically with a homogeneous population of superficial fibroblasts and keratinocytes is less fibrotic than that with a heterogeneous population of fibroblasts and keratinocytes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24090416     DOI: 10.1089/ten.TEA.2013.0434

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  14 in total

Review 1.  Extracellular Matrix and Dermal Fibroblast Function in the Healing Wound.

Authors:  Lauren E Tracy; Raquel A Minasian; E J Caterson
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-03-01       Impact factor: 4.730

Review 2.  Biology and principles of scar management and burn reconstruction.

Authors:  Edward E Tredget; Benjamin Levi; Matthias B Donelan
Journal:  Surg Clin North Am       Date:  2014-08       Impact factor: 2.741

3.  Gene expression in fetal murine keratinocytes and fibroblasts.

Authors:  Michael S Hu; Michael Januszyk; Wan Xing Hong; Graham G Walmsley; Elizabeth R Zielins; David A Atashroo; Zeshaan N Maan; Adrian McArdle; Danny M Takanishi; Geoffrey C Gurtner; Michael T Longaker; Hermann Peter Lorenz
Journal:  J Surg Res       Date:  2014-02-22       Impact factor: 2.192

4.  Human Skin Constructs with Spatially Controlled Vasculature Using Primary and iPSC-Derived Endothelial Cells.

Authors:  Hasan E Abaci; Zongyou Guo; Abigail Coffman; Brian Gillette; Wen-Han Lee; Samuel K Sia; Angela M Christiano
Journal:  Adv Healthc Mater       Date:  2016-06-22       Impact factor: 9.933

Review 5.  Advances in Skin Substitutes-Potential of Tissue Engineered Skin for Facilitating Anti-Fibrotic Healing.

Authors:  Mathew Varkey; Jie Ding; Edward E Tredget
Journal:  J Funct Biomater       Date:  2015-07-09

6.  Investigating the potential of Shikonin as a novel hypertrophic scar treatment.

Authors:  Chen Fan; Yan Xie; Ying Dong; Yonghua Su; Zee Upton
Journal:  J Biomed Sci       Date:  2015-08-16       Impact factor: 8.410

7.  Fn14, a Downstream Target of the TGF-β Signaling Pathway, Regulates Fibroblast Activation.

Authors:  Shaoxian Chen; Juli Liu; Min Yang; Wen Lai; Litong Ye; Jing Chen; Xinghua Hou; Hong Ding; Wenwei Zhang; Yueheng Wu; Xiaoying Liu; Shufang Huang; Xiyong Yu; Dingzhang Xiao
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

8.  Oxidized (non)-regenerated cellulose affects fundamental cellular processes of wound healing.

Authors:  M U Wagenhäuser; J Mulorz; W Ibing; F Simon; J M Spin; H Schelzig; A Oberhuber
Journal:  Sci Rep       Date:  2016-08-25       Impact factor: 4.379

Review 9.  The molecular basis of hypertrophic scars.

Authors:  Zhensen Zhu; Jie Ding; Edward E Tredget
Journal:  Burns Trauma       Date:  2016-01-21

Review 10.  Cultured epidermal stem cells in regenerative medicine.

Authors:  Catherine J Jackson; Kim Alexander Tønseth; Tor Paaske Utheim
Journal:  Stem Cell Res Ther       Date:  2017-07-04       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.